Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction

Clinical trial NCT05865132 · UNKNOWN

Trial details

NCT number: NCT05865132
Sponsor: AIPING ZHOU
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophagus Squamous Cell Carcinoma

Start date: 2023-04-06
Primary completion: 2025-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.